SCHEMBL8868484

SCHEMBL8868484

CCCOC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(=O)c3cc(OC)ccc3Cl)cc2)cn1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 1/20 0.48
P4HTM Q9NXG6 1/20 0.47
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
HTT P42858 1/20 0.45
NLRP3 Q96P20 2/20 0.42
BCL2L1 Q07817 1/20 0.41
MCL1 Q07820 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868432 0.93 NLRP3 (0.49) ALDH1A1LMNAMAPTP4HTMKMT2A
SCHEMBL8868784 0.93 P4HTM (0.51) ALDH1A1LMNASMN1; SMN2MAPTP4HTM
SCHEMBL9140771 0.92 ALDH1A1 (0.49) ALDH1A1LMNASMN1; SMN2MAPTP4HTM
SCHEMBL8869220 0.90 P4HTM (0.54) ALDH1A1LMNASMN1; SMN2MAPTP4HTM
SCHEMBL8868823 0.90 SMN1; SMN2 (0.50) ALDH1A1LMNASMN1; SMN2MAPTP4HTM
SCHEMBL8868488 0.90 LMNA (0.51) ALDH1A1LMNASMN1; SMN2MAPTP4HTM
SCHEMBL8868729 0.89 P4HTM (0.52) ALDH1A1LMNASMN1; SMN2MAPTP4HTM
SCHEMBL8868489 0.89 P4HTM (0.47) ALDH1A1LMNASMN1; SMN2MAPTP4HTM
SCHEMBL8869766 0.89 P4HTM (0.53) ALDH1A1LMNASMN1; SMN2MAPTP4HTM
SCHEMBL8867833 0.88 P4HTM (0.49) ALDH1A1LMNASMN1; SMN2MAPTP4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed